Also don't forget the background of the historic AML trials. An average Complete Response of 51% in Phase II trials that reported results between 1987 and 1994 [1]. It's a background that IMO potentially supports further confidence of a strong result in the Israel aka Sheba 2.0 trial.
[1] https://raceoncology.com/wp-content...e-a-review-of-the-literature-ijcrt-17-015.pdf
![]()
It was this historic consistency in performance that caused Dr T to stop and take a very careful look at Bisantrene when he reviewed ASX biotech tickers in alphabetical sequence in early 2019.
General Comments / Chat, page-7575
-
- There are more pages in this discussion • 3,531 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.83 |
Change
0.065(3.68%) |
Mkt cap ! $312.5M |
Open | High | Low | Value | Volume |
$1.78 | $1.86 | $1.78 | $226.8K | 123.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1717 | $1.84 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.85 | 632 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1717 | 1.835 |
2 | 2100 | 1.830 |
2 | 6542 | 1.825 |
2 | 2450 | 1.820 |
3 | 5677 | 1.815 |
Price($) | Vol. | No. |
---|---|---|
1.850 | 632 | 2 |
1.855 | 2229 | 1 |
1.860 | 8596 | 2 |
1.865 | 276 | 1 |
1.870 | 266 | 1 |
Last trade - 10.47am 11/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online